189 related articles for article (PubMed ID: 15576842)
1. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R
J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842
[TBL] [Abstract][Full Text] [Related]
2. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
3. Viral vector-mediated 12/15-lipoxygenase overexpression in vascular smooth muscle cells enhances inflammatory gene expression and migration.
Dwarakanath RS; Sahar S; Lanting L; Wang N; Stemerman MB; Natarajan R; Reddy MA
J Vasc Res; 2008; 45(2):132-42. PubMed ID: 17943024
[TBL] [Abstract][Full Text] [Related]
4. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
[TBL] [Abstract][Full Text] [Related]
5. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages.
Wen Y; Gu J; Vandenhoff GE; Liu X; Nadler JL
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1933-8. PubMed ID: 18296557
[TBL] [Abstract][Full Text] [Related]
6. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
[TBL] [Abstract][Full Text] [Related]
7. A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II.
Kim JA; Gu JL; Natarajan R; Berliner JA; Nadler JL
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):942-8. PubMed ID: 7600127
[TBL] [Abstract][Full Text] [Related]
8. The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.
Taylor AM; Hanchett R; Natarajan R; Hedrick CC; Forrest S; Nadler JL; McNamara CA
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2069-74. PubMed ID: 16037566
[TBL] [Abstract][Full Text] [Related]
9. Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.
Ibrahim AS; Saleh H; El-Shafey M; Hussein KA; El-Masry K; Baban B; Sheibani N; Wang MH; Tawfik A; Al-Shabrawey M
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):636-645. PubMed ID: 28351645
[TBL] [Abstract][Full Text] [Related]
10. 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB.
Bolick DT; Orr AW; Whetzel A; Srinivasan S; Hatley ME; Schwartz MA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2301-7. PubMed ID: 16166569
[TBL] [Abstract][Full Text] [Related]
11. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages.
Wen Y; Gu J; Chakrabarti SK; Aylor K; Marshall J; Takahashi Y; Yoshimoto T; Nadler JL
Endocrinology; 2007 Mar; 148(3):1313-22. PubMed ID: 17170102
[TBL] [Abstract][Full Text] [Related]
12. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells.
Limor R; Kaplan M; Sharon O; Knoll E; Naidich M; Weisinger G; Keidar S; Stern N
J Cell Biochem; 2009 Dec; 108(5):1203-10. PubMed ID: 19795383
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells.
Patricia MK; Natarajan R; Dooley AN; Hernandez F; Gu JL; Berliner JA; Rossi JJ; Nadler JL; Meidell RS; Hedrick CC
Circ Res; 2001 Apr; 88(7):659-65. PubMed ID: 11304487
[TBL] [Abstract][Full Text] [Related]
15. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway.
Scheidegger KJ; Butler S; Witztum JL
J Biol Chem; 1997 Aug; 272(34):21609-15. PubMed ID: 9261183
[TBL] [Abstract][Full Text] [Related]
17. Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis.
Katoh T; Lakkis FG; Makita N; Badr KF
Kidney Int; 1994 Aug; 46(2):341-9. PubMed ID: 7967345
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells.
Natarajan R; Rosdahl J; Gonzales N; Bai W
Hypertension; 1997 Oct; 30(4):873-9. PubMed ID: 9336387
[TBL] [Abstract][Full Text] [Related]
19. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats.
Yun YH; Kim HY; Do BS; Kim HS
Hypertens Res; 2011 Dec; 34(12):1313-20. PubMed ID: 21814216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
